摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(methyl-d3)tris((tri-tert-butylsilyl)amino)zirconium | 118141-85-8

分子结构分类

中文名称
——
中文别名
——
英文名称
(methyl-d3)tris((tri-tert-butylsilyl)amino)zirconium
英文别名
——
(methyl-d3)tris((tri-tert-butylsilyl)amino)zirconium化学式
CAS
118141-85-8
化学式
C37H87N3Si3Zr
mdl
——
分子量
752.575
InChiKey
TUQXIGJZFYPNRI-GSAFMDPUSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    13.74
  • 重原子数:
    44.0
  • 可旋转键数:
    7.0
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    36.09
  • 氢给体数:
    3.0
  • 氢受体数:
    3.0

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Hydrocarbon Activation via Reversible 1,2-RH-Elimination from (<sup>t</sup>Bu<sub>3</sub>SiNH)<sub>3</sub>ZrR:  Synthetic, Structural, and Mechanistic Investigations
    作者:Christopher P. Schaller、Christopher C. Cummins、Peter T. Wolczanski
    DOI:10.1021/ja950745i
    日期:1996.1.1
    Hydrocarbyl complexes, ((t)Bu(3)SiNH)(3)ZrR (1-R), were prepared via metatheses of ((t)Bu(3)SiNH)(3)ZrCl (1-Cl) with RMgX or RLi (R = Me, Et, Cy, CH(2)Ph, allyl, CH=CH2, Ph, CH(2)(t)Bu, C=CPh, C=C(t)Bu), through addition of isobutylene, H2C=C=CMe(2), and acetylene to 1-H (R = (i)Bu, dma, or CH=CH2), and by CH-bond activation; thermal 1,2-RH-elimination from 1-R produced putative ((t)Bu(3)SiNH)(2)Zr=NSi(t)Bu(3) (2), which was subsequently trapped by R'H. Thermolysis of 1-R (similar to 100 degrees C, R = Me or Cy) in the presence of H-2, c-C3H6, and CH4 in cyclohexane or neat C6H6, mesitylene, and toluene afforded 1-R (R = ii, Pr-c, Me, Ph, CH2-3,5-Me(2)C(6)H(3)) and a mixture of 1-CH(2)Ph and 1-C(6)H(4)Me, respectively. Exposure of 1-Cy to C2H4 or C6H6 in cyclohexane provided 1-CH=CH2 or 1-Ph, respectively, but further reaction produced 1(2)-(trans-HC=CH) and 1(2)-(p-C6H4) through double CH-bond activation. Thermolysis of ((t)Bu(3)SiND)(3)ZrCH3 (1-(ND)(3)-CH3) in C6H6 or C6D6 yielded CH3D, and 1C(6)H(5) or 1-(ND)(3)C6D5, through reversible benzene activation. Thermolysis of l-Cy in neat cyclohexane, and with C2H6 Or CMe(4) present, gave cyclometalation product ((t)Bu(3)SiNH)(2)ZrNHSi(t)Bu(2)CMe(2)CH(2) (3) and 1-NHSi(t)Bu(3). In THF, thermolysis of 1-CH3 afforded ((t)Bu(3)SiNH)(2)-(THF)Zr=NSi(t)Bu(3) (2-THF); at 25 degrees C, 1-H lost H-2 in the presence of L (L = THF, Et(2)O, NMe(3), PMe(3)) generating 2-L; 2-L (L = Et(2)O py) was also prepared via ligand exchange with 2-THF. Single crystal X-ray diffraction studies of 2-THF revealed a pseudotetrahedral core, with a long Zr=N bond distance (1.978(8) Angstrom), normal Zr-N(H) bond lengths (2.028(8), 2.031(8) Angstrom, similar amide (154.7(5), 158.1(5)degrees) and imide (156.9(5)degrees) bond angles, and little O(p pi) --> Zr(d pi) bonding. Crystal data: monoclinic, P2(1)/n, a = 13.312(5) Angstrom, b = 18.268(6) Angstrom, c = 20.551(7) Angstrom, beta = 92.30(3)degrees, Z = 4, T = 25 degrees C. 2-Et(2)O thermally eliminated C2H4 to give 1-OEt through gamma-CH activation. Kinetic isotope effects (KIE) on 1,2-RD-elimination from 1-(ND)(3)-R (95.7 degrees C, R = CH3, z(Me) = 6.3(1); CH(2)Ph, z(Bz) = 7.1(6); Ph, z(Ph) = 4.6(4)) and CD3H loss from 1-CD3((CH3)/k(CD3) = (z'(Me))(3) = 1.32) revealed a symmetric H-transfer in a loose transition state. 1,2-RH-elimination rates follow: (96.7 degrees C, k(R) (x10(4) s(-1)) = 22.6(2), Ph; 15.5(2), Pr-c; 13.2(4), CH=CH2; 10.4(2), Cy; 3.21(6), Et; 3.2(1), (i)Bu; 1.3(1), dma; 1.51(6), H; 1.42(4), CH(2)(t)Bu; 1.06(2), Me; 0.34(2), CH2-3,5-Me(2)C(6)H(3); 0.169(3), CH(2)Ph).Competition for ((t)Bu(3)SiNH)(2)Zr=NSi(t)Bu(3) (2) by RH/R'H and equilibria provided information about the stabilities of 1-R relative to 1-Pr-c (R = CPr (0.0 kcal/mol) < Ph (0.3) < CH(2)Ph (0.7) < Me (1.2) < CH(2)(t)Bu (greater than or equal to 7.6) < Et (greater than or equal to 7.8) < Cy (greater than or equal to 10.9)). Transition state energies afforded relative C-H bond activation selectivities (Delta Delta G double dagger relative to Pr-c-H): (PrH)-Pr-c approximate to ArH (0.0 kcal/mol) > MeH (3.4) > PhCH(2)H (4.0) > cyclometalation (greater than or equal to 8.5) > EtH(greater than or equal to 8.9) > (t)BuCH(2)H (greater than or equal to 9.3) > CyH (greater than or equal to 11.2). A correlation of Delta G double dagger(1,2-RH-elimination) with D(R-H) indicated generally late transition states but suggested an earlier composition for the alkyls, as rationalized through a Hammond analysis. Correlation of Delta G double dagger(1,2-RH-elimination) with RH proton affinity implicated tight binding of RH in the transition state and possible RH-binding intermediates (2-RH). 1,2-HC=CR-elimination from 1-C=CR was not observed, but second-order exchanges of 1-C=CPh with (t)BuC=CH, and 1-C=C(t)Bu with HC=CPh were indicative of an associative pathway. All data can be accommodated by the following mechanism: 1-R + R'H reversible arrow 2-RH + R'H reversible arrow 2-R'H + RH reversible arrow 1-R' + RH; a variant where 2 mediates reversible 2-RH + R'H exchange is less likely.
查看更多

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 (甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (反式)-4-壬烯醛 (双(2,2,2-三氯乙基)) (乙腈)二氯镍(II) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (±)17,18-二HETE (±)-辛酰肉碱氯化物 (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (s)-2,3-二羟基丙酸甲酯 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 ([2-(萘-2-基)-4-氧代-4H-色烯-8-基]乙酸) ([1-(甲氧基甲基)-1H-1,2,4-三唑-5-基](苯基)甲酮) (Z)-5-辛烯甲酯 (Z)-4-辛烯醛 (Z)-4-辛烯酸 (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-(+)-5,5'',6,6'',7,7'',8,8''-八氢-3,3''-二叔丁基-1,1''-二-2-萘酚,双钾盐 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-盐酸沙丁胺醇 (S)-溴烯醇内酯 (S)-氨氯地平-d4 (S)-氨基甲酸酯β-D-O-葡糖醛酸 (S)-8-氟苯并二氢吡喃-4-胺 (S)-7,7-双[(4S)-(苯基)恶唑-2-基)]-2,2,3,3-四氢-1,1-螺双茚满 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(((2,2-二氟-1-羟基-7-(甲基磺酰基)-2,3-二氢-1H-茚满-4-基)氧基)-5-氟苄腈 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-2-N-Fmoc-氨基甲基吡咯烷盐酸盐 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (SP-4-1)-二氯双(喹啉)-钯 (SP-4-1)-二氯双(1-苯基-1H-咪唑-κN3)-钯